Fosinopril/hydrochlorothiazide
| Combination of | |
|---|---|
| Fosinopril | Angiotensin converting enzyme inhibitor |
| Hydrochlorothiazide | Thiazide diuretic |
| Clinical data | |
| Trade names | Monopril HCT |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
Fosinopril/hydrochlorothiazide is the combination preparation of fosinopril, an angiotensin converting enzyme (ACE) inhibitor, and hydrochlorothiazide, a thiazide diuretic.[1]
References
- ^ O'Grady P, Yee KF, Lins R, Mangold B (1999). "Fosinopril/hydrochlorothiazide: single dose and steady-state pharmacokinetics and pharmacodynamics". Br J Clin Pharmacol. 48 (3): 375–81. doi:10.1046/j.1365-2125.1999.00013.x. PMC 2014346. PMID 10510149.
{{cite journal}}: Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link)
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |